# Trial of Oral Glutamine on Mitochondrial Function in CKD

> **NCT02838979** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 11 (actual)

## Conditions studied

- Cardiovascular Disease
- Sarcopenia
- Endothelial Dysfunction
- Muscle Mitochondrial Function
- Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** First Intervention (14 days)
- **OTHER:** Washout (3 weeks)
- **DIETARY_SUPPLEMENT:** Second Intervention (14 days)

## Key facts

- **NCT ID:** NCT02838979
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-25
- **Primary completion:** 2017-10-01
- **Final completion:** 2018-01-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-07-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838979, "Trial of Oral Glutamine on Mitochondrial Function in CKD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02838979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*